SEC Filing Summary: Eastside Distilling, Inc. (EAST)
Business Context and Reporting Period
This Form 8-K was filed on January 21, 2025, reporting events occurring between January 14, 2025, and January 21, 2025. The registrant is Eastside Distilling, Inc., a Nevada corporation trading on The Nasdaq Stock Market LLC under the symbol "EAST". The filing details recent capital raising activities and corporate governance amendments.
Key Financial Metrics and Capital Activities
The filing reports specific capital raising transactions rather than standard operating financial metrics (revenue, profit, cash flow, or margins are not disclosed in this document).
- Recent Sale (Jan 14, 2025): Sold 686,276 shares of Series G Convertible Preferred Stock and warrants to purchase 343,138 shares of Common Stock for gross proceeds of $350,000.
- Cumulative Offering (Since Nov 26, 2024): Total gross proceeds of $2,983,593 from the sale of 5,850,183 shares of Series G and warrants to purchase 2,925,091 shares of Common Stock.
- Offering Capacity: The total offering size was increased by the Board of Directors on January 17, 2025, to up to $5,037,800 (originally $3,037,800), allowing for up to 9,878,040 shares of Series G and warrants for 4,939,020 shares of Common Stock.
- Consultant Compensation: Issued 264,796 shares of Series G on January 21, 2025, as payment for past services. Future compensation may include up to $10,000 per month in stock.
- Use of Proceeds: Net proceeds are designated for working capital and general corporate purposes.
Material Changes and Corporate Actions
The following material changes were reported:
- Authorized Share Increase: On January 21, 2025, the Company filed a Certificate of Amendment increasing the authorized shares of Series G Preferred Stock from 6,000,000 to 11,000,000 shares.
- Offering Expansion: The Board approved an increase in the total offering size for the Series G and Warrant offering on January 17, 2025.
- Unregistered Sales: All reported sales were exempt from registration under Section 4(a)(2) of the Securities Act of 1933 and Rule 506(b).
Guidance, Risks, and Contingencies
The filing does not provide specific financial guidance, outlook, or management commentary regarding future operating performance. The primary contingency noted is the requirement for shareholder approval to issue stock in lieu of cash payments for the consultant's future monthly compensation.
Key Facts for Investor Verification
- Verify the dilution impact of the increased authorized Series G shares (now 11,000,000) and the remaining capacity in the $5,037,800 offering.
- Confirm the terms of the Series G Convertible Preferred Stock and Warrants as detailed in the December 3, 2024, Form 8-K (Exhibits 3(a)(1), 4(a), 10(a), 10(b)).
- Monitor the conversion mechanics of the Series G stock and the exercise price of the warrants to assess potential future common stock dilution.
- Review the specific valuation of the 264,796 Series G shares issued to the consultant to understand the implied equity value used for compensation.